5 (596) · $ 8.50 · In stock
A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.
Yuting Ke on LinkedIn: Bacteria can be engineered to fight cancer
New Type of Nanoparticle Can Perform Gene Editing in the Lungs
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
RTI Newsroom
Scientists develop microscopy technology that observes how new
Viral vectors and extracellular vesicles: innate delivery systems
Michaela Nicole Prado Larrea on LinkedIn: Investigation of the
Comprehensive review of CRISPR-based gene editing: mechanisms
Robust genome editing in adult vascular endothelium by
Researchers reveal that new compact version of Cas7-11 enzyme
An Interview with Colossal Biosciences CEO Ben Lamm
Targeting Gene Therapy Directly into the Lungs
Biomaterials for gene editing – facilitating CRISPR from the lab
News: Gene-Editing Tools: Delivery Methods and Challenges - CRISPR